NRGene Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 55
Employees
  • Stock Symbol
  • NRGN
Stock Symbol
  • Share Price
  • $8.95
  • (As of Sunday Closing)

NRGene General Information

Description

Energin R Technologies 2009 Ltd is a genomics company that provides turn-key solutions. It is engaged in developing AI based genomics software for seed and food companies. By applying vast proprietary databases and AI-based technologies, it provides international agriculture, seed and food companies, with computational tools to optimize and accelerate the breeding programs, significantly increasing crop yield and saving time and money.

Contact Information

Website
www.nrgene.com
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Stock Exchange
TAE
Primary Office
  • 5 Golda Meir Street
  • Ness Ziona 7403649
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NRGene Stock Performance

(As of Sunday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.95 $8.56 $8.41 - $9.23 7.6K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NRGene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NRGene‘s full profile, request access.

Request a free trial

NRGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Energin R Technologies 2009 Ltd is a genomics company that provides turn-key solutions. It is engaged in developing AI b
Biotechnology
Ness Ziona, Israel
55 As of 2020
0000
0000 0000-00-00
00000000 0000

00000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
0000000000000
Bangalore, India
00.000
000000000 00.000

0000000

t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labor
0000000000000
Branford, CT
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NRGene Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InterpretOmics Corporate Backed or Acquired Bangalore, India 00.000 000000000 00.000
0000000 Corporation Branford, CT
000000 00000000 Venture Capital-Backed Saint Sulpice, Switzerland 000 00000 00000000000 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

NRGene Executive Team (5)

Name Title Board Seat Contact Info
Gil Ronen Ph.D Co-Founder & Chief Executive Officer
Ehud Belder Chief Financial Officer
Guy Kol Co-Founder & Senior Vice President, Product & Strategic Alliances
Omer Barad Ph.D Vice President, Research & Development
You’re viewing 4 of 5 executive team members. Get the full list »

NRGene Board Members (1)

Name Representing Role Since
David Lieber NRGene Chairman 000 0000
To view NRGene’s complete board members history, request access »

NRGene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial